enGene Holdings Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ENGN Company Description
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
ENGN Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ENGN Smart Score
Score Breakdown
ENGN Company Description
Show More
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ENGN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ENGN's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on ENGN's company Twitter account
WallStreetBets
Number of mentions of ENGN in WallStreetBets Daily Discussion
ENGN News
Recent insights relating to ENGN
CNBC Recommendations
Recent picks made for ENGN stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ENGN
Corporate Flights
Flights by private jets registered to ENGN
Our Analysis